Table 2.
ADM USE | N | Median CRP* mg/dl (IQR) | N | Median IL6 pg/ml (IQR) |
---|---|---|---|---|
No | 3001 | 0.36 (0.16, 0.73) | 2966 | 1.92 (1.28, 2.95) |
Yes | 181 | 0.61 (0.34, 1.0) | 179 | 2.01 (1.26, 3.19) |
BDI ≥11 | N | Median CRP mg/dl (IQR) | N | Median IL6 pg/ml (IQR) |
---|---|---|---|---|
No | 2855 | 0.36 (0.16, 0.74) | 2822 | 1.88 (1.26, 2.93) |
Yes | 327 | 0.44 (0.19, 0.98) | 323 | 2.10 (1.54, 3.40) |
ADM=Antidepressant medication use; BDI = Beck Depression Inventory total score; CRP = C-reactive protein; IL6= Interleukin 6; and IQR=Interquartile Range.
p = 0.01 for the association of log transformed CRP and ADM use adjusted for age at randomization, BMI, sex, race/ethnicity, triglycerides, smoking, HOMA-IR, fasting glucose, BDI score, treatment group, anti-inflammatory medications, estrogen, systemic steroids, and statins in the linear regression analysis.